![We're All in This Together: Support and Solidarity for Our Heroes on the Front Lines - Union of Concerned Scientists We're All in This Together: Support and Solidarity for Our Heroes on the Front Lines - Union of Concerned Scientists](https://blog.ucsusa.org/wp-content/uploads/2020/03/1500-900-doctor-facemask.jpg)
We're All in This Together: Support and Solidarity for Our Heroes on the Front Lines - Union of Concerned Scientists
Springfield Cardinals - Take mom shopping at our Team Store on #MothersDay! All 𝘄𝗼𝗺𝗲𝗻'𝘀 𝗮𝗽𝗽𝗮𝗿𝗲𝗹 and 𝗰𝗮𝗽𝘀 will be 20% off beginning when gates open at 3:10 p.m. for our game vs.
![Dapagliflozin Did Not Significantly Reduce Organ Failure or Death in High-Risk Hospitalized COVID-19 Patients | DAIC Dapagliflozin Did Not Significantly Reduce Organ Failure or Death in High-Risk Hospitalized COVID-19 Patients | DAIC](http://www.dicardiology.com/sites/default/files/COVID_Forxinga_dapagliflozin_ACC21.jpg)
Dapagliflozin Did Not Significantly Reduce Organ Failure or Death in High-Risk Hospitalized COVID-19 Patients | DAIC
![ACC 2021: AstraZeneca's Farxiga failed to help COVID-19 patients, but it's safe for them to use | Fierce Pharma ACC 2021: AstraZeneca's Farxiga failed to help COVID-19 patients, but it's safe for them to use | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1621102632/Farxiga.jpg/Farxiga.jpg?VersionId=tKwGafVnkpAGsElslL8L7lhELjuoe0XG)
ACC 2021: AstraZeneca's Farxiga failed to help COVID-19 patients, but it's safe for them to use | Fierce Pharma
![Sodium‐Glucose Co‐Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes‐Induced Atherosclerotic Plaque Instability | Journal of the American Heart Association Sodium‐Glucose Co‐Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes‐Induced Atherosclerotic Plaque Instability | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/76fe1020-2b59-47d6-812c-8afaa871b300/jah37007-fig-0001.png)
Sodium‐Glucose Co‐Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes‐Induced Atherosclerotic Plaque Instability | Journal of the American Heart Association
![AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619989374/Farxiga%2010mg.jpg?VersionId=dHWdb1WN.E.nqpjVWVnOqyBuZk7JIEKD)
AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance | Fierce Pharma
![ACC 2021: AstraZeneca's Farxiga failed to help COVID-19 patients, but it's safe for them to use | Fierce Pharma ACC 2021: AstraZeneca's Farxiga failed to help COVID-19 patients, but it's safe for them to use | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1621102632/Farxiga.jpg/Farxiga.jpg?VersionId=tKwGafVnkpAGsElslL8L7lhELjuoe0XG)
ACC 2021: AstraZeneca's Farxiga failed to help COVID-19 patients, but it's safe for them to use | Fierce Pharma
![Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease | Journal of Investigative Medicine Serum high-molecular-weight adiponectin and response to dapagliflozin in patients with type 2 diabetes and non-alcoholic fatty liver disease | Journal of Investigative Medicine](https://jim.bmj.com/content/jim/69/7/1324/F2.large.jpg)